GlaxoSmithKline | GSK - 流动负债





流动负债 更改 日
AbbVie USD 41.64B 458M 2026-06
Alcon AG USD 3.17B 163M 2026-06
Almirall EUR 323.65M 26.99M 2026-06
Amgen USD 25.5B 547M 2026-06
argenx SE USD 1.58B 254.81M 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
Bayer EUR 32.27B 1.19B 2026-06
Biogen USD 3.9B 18.7M 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Eli Lilly USD 47B 745M 2026-09
Fresenius EUR 9.07B 468M 2026-06
Fresenius Medical Care EUR 7.18B 448.03M 2026-06
Genmab DKK 1.14B 38M 2026-06
Gilead Sciences USD 12B 982M 2026-09
GlaxoSmithKline GBP 20.72B 814M 2026-09
Glaxosmithkline GBP 22.43B 6.39B 2026-03
GRIFOLS EUR 2.24B 112M 2026-06
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Lakefront Biotherapeutics EUR 70.32M 30.1M 2026-06
Lonza CHF 3.57B 421M 2025-12
Merck EUR 8.12B 1.22B 2026-06
Merck USD 27.73B 786M 2026-06
Novartis USD 31.75B 374M 2026-06
Novo Nordisk DKK 239.08B 13.92B 2026-06
Orion EUR 491.8M 37.3M 2026-09
Pfizer USD 32.65B 1.7B 2026-06
Philips EUR 7.42B 8M 2026-06
Recordati EUR 1.4B 30.88M 2026-06
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 31.93B 1.92B 2026-06
Smith & Nephew USD 2.05B 510M 2026-06
UCB EUR 4.4B 470M 2025-12